- Palabras clave > accountability - pharmaceutical sector
- Palabras clave > corruption
- Palabras clave > ethics
- Palabras clave > Good Governance for Medicines (GGM)
- Palabras clave > key achievements
- Palabras clave > MeTA - The Medicines Transparency Alliance
- Palabras clave > pharmaceutical sector - good governance
- Palabras clave > progress report
- Palabras clave > strategies
- Palabras clave > transparency
(2016; 95 pages)
The Medicines Transparency Alliance (MeTA) initiative, implemented in seven countries (Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia) from 2008 to 2015, sought to test the hypothesis that increasing transparency and accountability in the pharmaceutical sector would improve access to medicines by improving decision-making.
This study investigates the activities undertaken to increase transparency and foster accountability, and how these two goals are related to each other and to program outputs and outcomes. Focusing mainly on Phase II of MeTA (August 2011 – December 2015), we used case study methods and reviewed archival data to document transparency and accountability mechanisms. After completing the individual cases, we then conducted cross-case analysis to examine themes and note similarities and differences across countries.